Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
15.10
-0.02 (-0.13%)
May 22, 2026, 4:00 PM EDT - Market closed

IART Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1759671,7503,4044,6905,678
Market Cap Growth
17.27%-44.73%-48.59%-27.42%-17.39%3.71%
Enterprise Value
2,9502,5963,4134,7475,7966,756
Last Close Price
15.1012.4222.6843.5556.0766.99
PE Ratio
---51.8525.9633.83
Forward PE
6.135.218.8312.9416.1620.19
PEG Ratio
1.04-6.171.541.681.36
PS Ratio
0.710.591.092.213.013.68
PB Ratio
1.130.931.132.142.603.37
P/TBV Ratio
1.110.911.132.202.603.40
P/FCF Ratio
287.92-70.1146.5821.1221.48
P/OCF Ratio
16.4419.2013.5324.3217.7418.17
EV/Sales Ratio
1.791.592.123.083.724.38
EV/EBITDA Ratio
9.57-20.1620.2016.2321.31
EV/EBIT Ratio
19.01-120.1242.5624.2634.26
EV/FCF Ratio
723.07-136.7064.9526.1025.55
Debt / Equity Ratio
1.911.811.251.040.870.94
Debt / EBITDA Ratio
--11.727.164.525.21
Debt / FCF Ratio
499.87-79.5023.017.276.25
Net Debt / Equity Ratio
1.701.701.110.860.640.68
Net Debt / EBITDA Ratio
-5.66-5.1810.115.843.243.59
Net Debt / FCF Ratio
434.79-56.9868.5418.785.224.30
Asset Turnover
0.460.430.410.400.410.42
Inventory Turnover
1.601.741.781.841.831.91
Quick Ratio
1.531.190.591.852.242.19
Current Ratio
3.382.541.173.453.623.39
Return on Equity (ROE)
-47.54%-39.90%-0.44%3.99%10.35%10.57%
Return on Assets (ROA)
-12.02%-11.84%0.28%2.43%5.26%4.20%
Return on Invested Capital (ROIC)
-14.22%-13.89%0.32%2.92%6.54%5.25%
Return on Capital Employed (ROCE)
-14.63%-15.76%0.86%3.17%6.82%5.93%
Earnings Yield
---1.93%3.85%2.96%
FCF Yield
0.35%-1.43%2.15%4.74%4.66%
Buyback Yield / Dilution
-0.13%0.44%4.14%3.81%2.30%-0.30%
Total Shareholder Return
-0.13%0.44%4.14%3.81%2.30%-0.30%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q